After participating in this educational activity, the participant should be better able to:
A mong the millions of patients admitted to intensive care units (ICUs) annually, approximately one in three will receive mechanical ventilation (1) . Of these, 5% to 10% will transition from acute to chronic critical illness and receive prolonged mechanical ventilation (PMV), defined as ventilation for Ն4 days with tracheostomy placement or for Ն21 days without tracheotomy (2-4). The majority of PMV patients die within 6 mos at the same time also accruing total annual costs exceeding $20 billion (3, (5) (6) (7) (8) . Survivors often have poor quality of life, pervasive functional and cognitive disability, and intense caregiving needs (7, 9, 10) . Despite these poor outcomes, the incidence of PMV has been increasing out of proportion to that of mechanical ventilation itself and is forecast to double during the coming decade (8, 11) .
One explanation for the growth of PMV is that the decision to pursue this level of care may be based on inadequate surrogate-physician interactions (12) . Surrogates often lack knowledge of patients' wishes for life support and have poor comprehension of their medical problems (13, 14) . Additionally, others have reported potential contributing deficiencies in ICU-based surrogate-physician communication (12, 13, 15, 16) . However, the physician-surrogate interaction has been infrequently described in the unique setting of PMV consideration, in which a patient has survived an acute illness but yet failed to improve sufficiently to be independent of life support.
In this prospective study, we hypothesized that surrogate-physician concordance in expected long-term patient outcomes would be poor but that physicians' predictions would be substantially better than those of surrogates. We also aimed to characterize important elements of the surrogate-physician interaction surrounding PMV provision.
METHODS

Study Design and Study Participants
This prospective study was conducted at Duke University Medical Center between April 2006 and April 2008. Study staff consecutively identified patients by screening all adult ICUs daily between April 2006 and April 2007. Patients were eligible if they were Ն18 yrs of age, had an identifiable surrogate, and had either a) received mechanical ventilation for Ն21 days with Ͻ48 hrs of unassisted breathing or b) had received Ն4 days of mechanical ventilation and had undergone tracheostomy placement within the previous 48 hrs (2). Exclusions were tracheostomy performed either for an emergency or for an ear-, nose-, and throatrelated diagnosis. "Surrogate" was defined as the person most involved in the decision to place a tracheostomy and the most likely to provide postdischarge caregiving. The Duke University Institutional Review Board approved the protocol.
Hospital Outcomes
Study staff abstracted medical charts to determine patient sociodemographics, length of stay, duration of ventilation, admitting diagnoses, Acute Physiology and Chronic Health Evaluation II-derived Acute Physiology Score, respiratory and laboratory values, and discharge disposition (17) .
Interviews and Follow-Up
The timeline of data collection is shown in Figure 1 . Baseline (in-hospital) interviews were conducted in person with surrogates, the primary ICU physician involved in the decision to proceed with tracheostomy, and patients (if possible) within 48 hrs of tracheostomy placement. Follow-up interviews were performed either by telephone or in person with surrogates and patients at both 3 mos and 12 mos after enrollment, although we report only 12-mo surrogate responses here. A total of 100% of interviews were completed for physicians at baseline as well as surrogates at baseline and 12 mos.
During baseline interviews, surrogates completed a questionnaire developed and piloted in a similar population by our group that assessed specific communication, content, and decision-making qualities including: whether physicians addressed major risks and implications of PMV provision; who was the primary information source regarding PMV provision; how well surrogates thought physicians explained what to expect for patient outcomes; degree of surrogate-physician conflict regarding PMV decision; overall satisfaction with communication; and overall perceived quality of communication. Surrogates and physicians also answered questions regarding expectations for 1-yr patient survival, functional status, and quality of life. Possible responses to these items were "strongly disagree," "disagree," "agree," and "strongly agree."
Vital status at each follow-up was determined by chart review or surrogate interview. Patient functional status was measured in follow-up by surrogate report using a six-item instrument addressing limitations in basic daily activities of living (bathing, dressing, feeding, transferring from bed to chair, bladder and bowel control, and use of the toilet) (18) . To assess patient quality of life, surrogates completed the EuroQOL-5D (EQ-5D), a five-domain, preference-based measure used and validated among critical illness survivors and their surrogates (19, 20) . An EQ-5D index score calculated from domain scores can range from 0 (death) to 1 (excellent quality of life). We report surrogate EQ-5D reports because only 49 patients (39%) were able to complete 12-mo interviews. However, Pearson's correlations for surrogate and patient EQ-5D scores were high (r ϭ .94, p Ͻ .0001), whereas the within-pair mean difference was only 0.09 (0.11), similar to past studies (21) .
Statistical Analyses
The primary aims were to determine both the concordance of surrogate and physician expectations for 1-yr patient outcomes (survival, functional status, and quality of life) as well as the accuracy of these expectations. We defined "high expectations" as a response of either "strongly agree" or "agree" to questions regarding whether or not patients were expected a) to survive 1 yr; b) to be independent of any major functional limitations; or c) to have a good quality of life 1 yr after tracheostomy placement. "Low expectations" reflected responses of "disagree" or "strongly disagree." We defined "good functional status" as the absence of any dependency in activities of daily living (18) . "Good quality of life" was defined as an EQ-5D index score of Ͼ0.44, a cutoff 2 standard deviations below the population average for persons of age 55 to 65 yrs (22) .
We performed descriptive analyses, using means and medians for continuous variables and frequencies for categorical variables. McNemar's tests and weighted coefficients were used to describe differences in surrogatephysician pairs' expectations for patients' 1-yr survival, functional status, and quality of life. The coefficients Ͻ0.20 represent poor agreement (23) . State software (version 10, College Station, TX) was used for statistical analyses.
RESULTS
Characteristics of Participants
Patients were generally middle-aged, married, insured, and functionally independent before hospitalization (Table 1) . They received care in neurologic (n ϭ 43, 34%), general surgical/trauma (n ϭ 33, 26%), cardiothoracic (n ϭ 23, 18%), medical (n ϭ 19, 15%), cardiac (n ϭ 8, 5%), and ICUs. Surrogates were predominantly female (70%); half were patients' spouses. We interviewed 54 physicians, 47 attendings (87%), and seven fellows (13%), who cared for two study patients each on average (range, 1-10).
Hospital Course and Observed 1-Yr Outcomes
A total of 70 patients (56%) survived 1 yr after tracheostomy placement, although only 11 (9%) of these survivors had good functional status and 37 (33%) had a good quality of life as assessed by surrogates (Table 2) . Fortythree (61%) of the 70 1-yr survivors still required daily informal caregiver assistance. Of these caregivers, 21 (49%) reported "a lot" or "severe" stress associated with caregiving and 36 (84%) had either quit their job or had significantly altered their work schedule to accommodate their caregiving. 
Surrogate-Physician Interactions
Only 33 surrogates (26%) reported that physicians discussed their loved one's prognosis for survival, functional limitations, quality of life, or expected caregiving needs. Also, just 26 surrogates (21%) reported that physicians had discussed potential consequences of tracheostomy placement including procedural risks, impact on discharge disposition, need for long-term ventilatory support, and feeding route. Forty-four surrogates (35%) felt that attending physicians were not the primary source of information about tracheostomy and PMV. In other cases, nurses (19%), respiratory therapists (8%), residents (8%), and social workers (5%) were the primary informants. A total of 39 respondents (31%) believed that physicians, not themselves, made the decision to provide PMV. Surrogates opted for tracheostomy placement to expedite weaning or improve comfort (45%), because they felt that the physician wanted them to do it (28%), to keep the patient alive (23%), because they were unaware of an alternative (5%), or to cure the patient (3%). Serious conflicts with physicians over the tracheostomy decision were reported by 13 surrogates (12%). Overall, 91 surrogates (72%) felt satisfied with physician communication and 84 (67%) described the quality of surrogate-physician communication as either "extremely good" or "good."
Concordance and Accuracy of Surrogate and Physician Expectations
Surrogates had higher expectations than physicians for patient survival, functional status, and quality of life (all p Ͻ .0001 by McNemar's tests). Most surrogates expected patients to survive (n ϭ 117, 93%) as well as to have no major functional limitations (n ϭ 90, 71%) and a good quality of life (n ϭ 105, 83%) at 1 yr. In contrast, 55 physicians (44%) had high expectations for patient survival, whereas only seven (6%) expected patients to be free from major limitations in functional status and five (4%) believed they would have a good quality of life.
Both surrogate-physician concordance in expectations (all ϭ Ͻ0.08) and accuracy of outcome prediction was low (Tables  3-5) . Although 79 surrogates (63%) and 91 physicians (72%) accurately predicted patients' 1-yr survival, only 56 pairs (44%) were both concordant and accurate (Table  3) . Among the surrogates of the 56 patients who died within 1 yr, most expected these same patients to have no major functional limitations (n ϭ 40, 71%) and a good quality of life (n ϭ 46, 82%).
The expectations of 52 surrogates (41%) and 93 physicians (74%) were accurately aligned with patients' actual 1-yr limitations in functional ability (Table 4) . A total of 39 of surrogate-physician pairs (31%) agreed on expected functional status, whereas just 29 surrogate-physician pairs' (23%) expectations matched actual clinical outcomes.
Similarly, 37 patients (53%) who survived 1 yr were perceived to have poor quality of life at 1 yr (Table 5) . A total of 78 surrogates (62%) and 45 physicians (36%) predicted accurately patients' 1-yr quality of life. As pairs, 69 surrogatephysician dyads (55%) agreed about expected quality of life, whereas just 33 dyads' (26%) expectations were both concordant and accurate compared with observed quality of life.
DISCUSSION
Decision making in the setting of chronic critical illness is difficult for all involved. One year after the decision to pursue PMV, only 11 (9%) were alive and functionally independent.
These outcomes stand in sharp contrast to surrogate-physician pairs' unreasonably high expectations, their low dyadic concordance, and their nearly equal inaccuracy in predicting these observed outcomes.
Surrogates in our study had an especially poor understanding of likely outcomes. However, surrogates' unreasonably high expectations are not surprising, given that physicians seemed to provide them infrequently with the basic information necessary for decision making about prolonged life support. Only one quarter of surrogates reported that physicians discussed prognosis, whereas another third obtained the majority of their information from nonphysicians. This observation may reflect physicians' general discomfort both with discussing prognosis and in withholding or with- Surr., surrogate; MD, physician; CI, confidence interval. a "High" represents original responses of "strongly agree" and "agree" whereas "low" represents original responses of "disagree" and "strongly disagree" to queries about expectations for 1-yr survival;
b p values from McNemar's tests represent if there is a significant difference in concurrence of expectations between surrogates and physicians (whether they both agree or both disagree); all p Ͻ .001 after adjustment for potential cluster effect of individual physicians using conditional logistic regression, as well;
c r values from Spearman's rank-correlation test; p Ͻ .01. Total n ϭ 126 surrogate-physician pairs. Surr., surrogate; MD, physician; CI, confidence interval. a "High" represents original responses of "strongly agree" and "agree" whereas "low" represents original responses of "disagree" and "strongly disagree" to queries about expectations for lack of major functional limitations;
c r values from Spearman's correlations; p Ͻ .01. Total n ϭ 126 surrogate-physician pairs. Surr., surrogate; MD, physician; CI, confidence interval.
a "High" represents original responses of "strongly agree" and "agree" whereas "low" represents original responses of "disagree" and "strongly disagree" to queries about expectations for good quality of life; drawing life support in the face of prognostic uncertainty (24, 25) . It could also represent surrogates' overwhelming stress or poor comprehension of a loved one's medical condition (13, 26) . Physicians' predictions for survival were slightly more accurate, although they were poor at predicting future quality of life. The best known ICU-based predictive models for survival have poor accuracy for those who have received prolonged life support, however (27) . Furthermore, physicians may simply be unaware of the poor outcomes of PMV recipients (6, 12) .
Although previous studies have demonstrated that severely ill patients and their surrogates are more optimistic than physicians, the dramatic difference in expectations we observed between these groups suggests that the overall effective transfer of information and comprehension of the patient's condition was problematic as well (28) . Nearly a third of surrogates reported that physicians, not themselves, made the decision to place a tracheostomy-a finding that conflicts with most surrogates' preferred role as direct participants in decision making (29) . It also seems that physicians commonly failed to optimize shared decisionmaking by omitting discussion of alternatives, potential complications, and likely outcomes. However, physicians' avoidance of discussing prognosis conflicts with surrogates' wishes for disclosure of these estimates, even when the outcome is indefinite (30) . Other factors also could have represented barriers to surrogate-physician alignment of expectations including surrogates' numeracy, education level, language, and cultural differences; the high prevalence of surrogate psychological and financial distress suffered during the ICU care of their loved one; and the multiple provider ICU environment (26) .
Overall, these summed deficiencies in the surrogate-physician interaction likely heightened the general sense of uncertainty in the decision-making process surrounding the provision of PMV. With substantial uncertainty in prognosis and patient preferences for life support, more frequent provision of PMV would be expected (12, 28, 31, 32) . However, this default strategy was associated with unanticipated high mortality, profound and chronic disability, as well as significant financial stress and caregiving demands for families-the same poor outcomes that most adults with serious illness report that they would choose to avoid were they to understand the risk (33) .
What can be done to help decision makers set reasonable goals for patient care as well as to plan for the unique needs of patients who subsequently transition from acute to chronic critical illness? Physicians should openly discuss with surrogates both short-and longterm patient prognosis as well as the caregiving burden associated with course of PMV. They should also attempt to understand not only surrogates' expectations and comprehension of prognosis but why surrogates' perceptions may be misaligned with their own (13) . Family members value information about diagnosis, prognosis, and treatment alternatives even when outcomes are unclear (12, 30, 34) . Communication interventions in the setting of critical care, such as informational leaflets and a protocolbased family conference, can improve comprehension and reduce psychological distress (35, 36) . Clinicians also can be trained effectively in communication skills (37) . Skilled communication may ensure a patient's wishes are followed appropriately, can result in reduction in time spent in the ICU before death, and has been associated with increased family satisfaction (38 -42) . A recently published mortality prediction model for PMV may inform the discussion between surrogates and clinicians and improve prognostic accuracy (43) . Decision aids could assist surrogates to navigate the complexities of intensive care (44) . Enhancing communication between physicians and decision makers, particularly when considering treatments for those receiving mechanical ventilation, represents an unmet need as recently emphasized by both the National Institutes of Health and the Joint Commission on the Accreditation of Hospitals (45, 46).
Our study has limitations worth noting. Although our cohort was enrolled consecutively from a diverse group of ICUs, the findings of a single center study may not reflect the experience of other medical centers. We used proxy measures of health status and quality of life in our analyses that could have underestimated patients' perceptions of these outcomes. However, surrogates' and patients' measures were highly correlated and the absolute difference between groups' scores was low. Furthermore, a large number of patients were unable to complete interviews because of disability during follow-up, although this observation itself is testament to the profound disability the patients experienced. Finally, because we did not audiotape family meetings, we can rely only on surrogates' potentially inaccurate descriptions of these interactions.
CONCLUSIONS
The substituted judgment of a surrogate is an integral but complicated component of the decision to provide PMV (47) . This decision has important implications for patients, their families, healthcare providers, and the healthcare system (6). We found a dramatic degree of surrogate-physician discord and inaccuracy in expectations for outcomes that seemed to be related to the content of ICU-based interactions. At the time surrogates made the decision to proceed with the provision of PMV, they expected neither the profound disability patients later experienced nor its associated caregiver burden. Improving the content and quality of the surrogate-physician interaction should be a target for future study in this challenging, expanding population of chronically critically ill patients (11, 48 -50) .
